Clinical Trial

OBSiDiAN in a Stapled Circular Esophagogastric Anastomosis After Ivor Lewis Esophagectomy

Study acronym: Obsidian ph II
Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
Oesophagectomy is very invasive surgery. A leakage at the level of the connection between oesophagus and stomach made during surgery causes a lot more problems and can lead to death. Studies show that the leakage rate sometimes goes up to 40 per cent. The chance of dying if you develop a leak after surgery is 15%, while the overall chance of dying during hospitalisation for this procedure is about 4%. We want to investigate whether the use of this new type of 'glue' (Obsidian®) can reduce the number of leaks. We invite you to participate in a clinical trial with the aim of investigating whether Obsidian® is safe and can reduce the number of leaks after oesophageal surgery in patients with oesophageal cancer. We want to apply a new type of 'glue', Obsidian®, at the level of the new connection between oesophagus and stomach.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2023-02-01; most recent amendment 2025-03-28.
Status change: Withdrawn → Not Yet Recruiting 2025-03-28
Status change: Not Yet Recruiting → Withdrawn 2024-01-09
Trial Details
NCT Number NCT05713955
Lead Sponsor University Hospital, Ghent
Collaborators: Vivostat
Conditions Anastomotic Leak Esophagus
Enrollment 90 participants
Start Date 2025-04-01
Primary Completion 2028-04-01 (estimated)
Study Completion 2029-04-01 (estimated)
Updated on ClinicalTrials.gov 2025-04-02